Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

209 studies match

clinicaltrialsPublishedShowing 1–50 of 209 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05006716	A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies(CaDAnCe-101)	recruiting	Phase 1 / Phase 2	645	BeOne MedicinesINDUSTRY	16	Sep 28, 2026	clinicaltrials
NCT03145181	Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma(MajesTEC-1)	active not recruiting	Phase 1	302	Janssen Research & Development, LLCINDUSTRY